The SCD was not superior to the MD to achieve symptomatic remission, FC response, and CRP response. Given these results, the greater ease of following the MD and other health benefits associated with the MD, the MD may be preferred to the SCD for most patients with CD with mild to moderate symptoms. The gene discussed is CRP; the disease is Schnyder corneal dystrophy.